Investigation into KORE Group's Merger Agreement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy KORE?
Source: PRnewswire
- Merger Agreement Investigation: Levi & Korsinsky, LLP has initiated an investigation into potential breaches of fiduciary duty by KORE Group's Board of Directors regarding a definitive merger agreement with Searchlight Capital Partners and Abry Partners, offering shareholders $9.25 per share in cash.
- Shareholder Rights Concern: The investigation focuses on whether the Board violated its fiduciary duties to shareholders, which could undermine shareholder confidence in the merger agreement and affect future investment decisions.
- Legal Support Information: Levi & Korsinsky offers no-cost legal consultations to assist shareholders in understanding their rights and participating in potential legal actions, thereby enhancing shareholder awareness of corporate governance issues.
- Law Firm Background: Levi & Korsinsky is a nationally recognized firm with extensive experience in securities litigation, having recovered hundreds of millions for investors, demonstrating its capability and influence in protecting shareholder interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KORE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KORE
Wall Street analysts forecast KORE stock price to fall
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 9.110
Low
5.00
Averages
5.00
High
5.00
Current: 9.110
Low
5.00
Averages
5.00
High
5.00
About KORE
KORE Group Holdings, Inc. is a global pure-play Internet of Things (IoT) hyperscaler and provider of IoT connectivity, solutions, and analytics. The Company is a global independent IoT enabler, delivering critical services globally to customers to deploy, manage, and scale their IoT application and use cases. It provides advanced connectivity services, location-based services, device solutions, and managed and professional services used in the development and support of IoT solutions and applications. It provides connectivity and IoT solutions to enterprise customers across five industry verticals, comprising of connected health, fleet management, asset monitoring, retail communications services and industrial IoT. The Company has built a platform to serve its clients in three areas: connectivity-as-a-service (CaaS), IoT managed services/solutions, and analytics, which the Company refers to as CSA, or connectivity, solutions, and analytics.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investigation into KORE Group's Merger Agreement
- Merger Agreement Investigation: Levi & Korsinsky, LLP has initiated an investigation into potential breaches of fiduciary duty by KORE Group's Board of Directors regarding a definitive merger agreement with Searchlight Capital Partners and Abry Partners, offering shareholders $9.25 per share in cash.
- Shareholder Rights Concern: The investigation focuses on whether the Board violated its fiduciary duties to shareholders, which could undermine shareholder confidence in the merger agreement and affect future investment decisions.
- Legal Support Information: Levi & Korsinsky offers no-cost legal consultations to assist shareholders in understanding their rights and participating in potential legal actions, thereby enhancing shareholder awareness of corporate governance issues.
- Law Firm Background: Levi & Korsinsky is a nationally recognized firm with extensive experience in securities litigation, having recovered hundreds of millions for investors, demonstrating its capability and influence in protecting shareholder interests.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Centessa Pharmaceuticals plc, KORE Group Holdings, Inc., and Clearwater Analytics Holdings, Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders.
- Transaction Details: Centessa Pharmaceuticals is being sold to Eli Lilly for $38.00 per share in cash plus a non-transferrable right worth up to $9.00, KORE Group is selling to Searchlight Capital Partners and Abry Partners for $9.25 per share, while Clearwater Analytics is being sold to Permira and Warburg Pincus for $24.55 per share.
- Shareholder Rights: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options at no cost, aiming to secure increased consideration and additional disclosures for shareholders involved in these transactions.
- Legal Support: The firm represents investors globally, focusing on securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, which underscores their expertise in protecting investor rights.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating the merger between BT Brands, Inc. (NASDAQ: BTBD) and Aero Velocity Inc., with BT Brands shareholders expected to own approximately 11% of the combined company post-transaction, potentially impacting shareholder rights and future returns.
- Shareholder Rights Protection: The law firm encourages KORE Group Holdings, Inc. (NYSE: KORE) shareholders to pay attention to the sale to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share, ensuring shareholders are informed of their rights and options to protect their interests.
- Executive Transaction Scrutiny: FONAR Corporation (NASDAQ: FONR) is set to sell to CEO Timothy Damadian and other executives at $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, with Halper Sadeh LLC potentially seeking increased compensation and disclosures for shareholders.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, ensuring no upfront costs for clients, aiming to protect global investors and secure their rights and compensation in cases of securities fraud and corporate misconduct.
See More
KORE Launches SGP.32 Connectivity Solutions for Global IoT
- New Connectivity Solutions: KORE, in partnership with Kigen, has announced the launch of SGP.32-compliant connectivity solutions, set for commercial availability in 2026, aimed at simplifying enterprise IoT deployments and enhancing global connectivity capabilities, which is expected to significantly boost operational efficiency and market competitiveness for customers.
- Diverse Device Support: The solution supports a wide range of devices, from high-power gateways to battery-powered sensors, offering various connectivity profiles tailored to different operational needs, helping enterprises manage connectivity flexibly in complex network environments.
- Cost Reduction: By enabling remote provisioning and optimization of connectivity, KORE's SGP.32 solutions allow enterprises to reduce on-site service requirements, thereby lowering operational costs and enhancing flexibility in device management, driving scalable IoT applications.
- Standardization in the Industry: KORE's solutions are built on the GSMA's next-generation eSIM standard, ensuring deep collaboration with global carriers, which helps enterprises maintain competitiveness in a rapidly changing market while meeting evolving regulatory requirements.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating companies like Apellis Pharmaceuticals, KORE Group Holdings, and Centessa Pharmaceuticals for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Apellis Transaction Details: Apellis Pharmaceuticals is being sold to Biogen Inc. for $41.00 per share in cash, along with a non-transferable right to receive two payments of $2.00 each, contingent on meeting specific global net sales thresholds, potentially affecting shareholder returns.
- KORE Transaction Situation: KORE Group Holdings is being sold for $9.25 per share to Searchlight Capital Partners and Abry Partners, prompting shareholders to consider the implications of this transaction on their rights and available legal options.
- Centessa Transaction Analysis: Centessa Pharmaceuticals is being sold for $38.00 per share in cash, plus a non-transferable right entitling holders to receive up to $9.00 upon achieving certain milestones, urging shareholders to understand their legal rights and options.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Affinity Bancshares, Inc. and Fidelity Bancshares, where Affinity shareholders are expected to receive $23.00 per share in cash, significantly impacting shareholder returns.
- Apellis Pharmaceutical Deal: In the transaction between Apellis Pharmaceuticals, Inc. and Biogen, Apellis shareholders are expected to receive $41.00 per share in cash along with two non-transferable rights of $2.00 each, providing additional potential earnings and enhancing investment appeal.
- Olaplex Acquisition Case: In the deal between Olaplex Holdings, Inc. and Henkel US Operations, Olaplex shareholders are expected to receive $2.06 per share in cash, offering direct cash returns to shareholders and boosting market confidence.
- KORE Group Transaction: In the transaction involving KORE Group Holdings, Inc. and Searchlight Capital Partners, KORE shareholders are expected to receive $9.25 per share in cash, providing substantial cash flow to shareholders and further solidifying their market position.
See More
Investigation into KORE Group's Merger Agreement
- Merger Agreement Investigation: Levi & Korsinsky, LLP has initiated an investigation into potential breaches of fiduciary duty by KORE Group's Board of Directors regarding a definitive merger agreement with Searchlight Capital Partners and Abry Partners, offering shareholders $9.25 per share in cash.
- Shareholder Rights Concern: The investigation focuses on whether the Board violated its fiduciary duties to shareholders, which could undermine shareholder confidence in the merger agreement and affect future investment decisions.
- Legal Support Information: Levi & Korsinsky offers no-cost legal consultations to assist shareholders in understanding their rights and participating in potential legal actions, thereby enhancing shareholder awareness of corporate governance issues.
- Law Firm Background: Levi & Korsinsky is a nationally recognized firm with extensive experience in securities litigation, having recovered hundreds of millions for investors, demonstrating its capability and influence in protecting shareholder interests.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Centessa Pharmaceuticals plc, KORE Group Holdings, Inc., and Clearwater Analytics Holdings, Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders.
- Transaction Details: Centessa Pharmaceuticals is being sold to Eli Lilly for $38.00 per share in cash plus a non-transferrable right worth up to $9.00, KORE Group is selling to Searchlight Capital Partners and Abry Partners for $9.25 per share, while Clearwater Analytics is being sold to Permira and Warburg Pincus for $24.55 per share.
- Shareholder Rights: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options at no cost, aiming to secure increased consideration and additional disclosures for shareholders involved in these transactions.
- Legal Support: The firm represents investors globally, focusing on securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, which underscores their expertise in protecting investor rights.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating the merger between BT Brands, Inc. (NASDAQ: BTBD) and Aero Velocity Inc., with BT Brands shareholders expected to own approximately 11% of the combined company post-transaction, potentially impacting shareholder rights and future returns.
- Shareholder Rights Protection: The law firm encourages KORE Group Holdings, Inc. (NYSE: KORE) shareholders to pay attention to the sale to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share, ensuring shareholders are informed of their rights and options to protect their interests.
- Executive Transaction Scrutiny: FONAR Corporation (NASDAQ: FONR) is set to sell to CEO Timothy Damadian and other executives at $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, with Halper Sadeh LLC potentially seeking increased compensation and disclosures for shareholders.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, ensuring no upfront costs for clients, aiming to protect global investors and secure their rights and compensation in cases of securities fraud and corporate misconduct.
See More
KORE Launches SGP.32 Connectivity Solutions for Global IoT
- New Connectivity Solutions: KORE, in partnership with Kigen, has announced the launch of SGP.32-compliant connectivity solutions, set for commercial availability in 2026, aimed at simplifying enterprise IoT deployments and enhancing global connectivity capabilities, which is expected to significantly boost operational efficiency and market competitiveness for customers.
- Diverse Device Support: The solution supports a wide range of devices, from high-power gateways to battery-powered sensors, offering various connectivity profiles tailored to different operational needs, helping enterprises manage connectivity flexibly in complex network environments.
- Cost Reduction: By enabling remote provisioning and optimization of connectivity, KORE's SGP.32 solutions allow enterprises to reduce on-site service requirements, thereby lowering operational costs and enhancing flexibility in device management, driving scalable IoT applications.
- Standardization in the Industry: KORE's solutions are built on the GSMA's next-generation eSIM standard, ensuring deep collaboration with global carriers, which helps enterprises maintain competitiveness in a rapidly changing market while meeting evolving regulatory requirements.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating companies like Apellis Pharmaceuticals, KORE Group Holdings, and Centessa Pharmaceuticals for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Apellis Transaction Details: Apellis Pharmaceuticals is being sold to Biogen Inc. for $41.00 per share in cash, along with a non-transferable right to receive two payments of $2.00 each, contingent on meeting specific global net sales thresholds, potentially affecting shareholder returns.
- KORE Transaction Situation: KORE Group Holdings is being sold for $9.25 per share to Searchlight Capital Partners and Abry Partners, prompting shareholders to consider the implications of this transaction on their rights and available legal options.
- Centessa Transaction Analysis: Centessa Pharmaceuticals is being sold for $38.00 per share in cash, plus a non-transferable right entitling holders to receive up to $9.00 upon achieving certain milestones, urging shareholders to understand their legal rights and options.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Affinity Bancshares, Inc. and Fidelity Bancshares, where Affinity shareholders are expected to receive $23.00 per share in cash, significantly impacting shareholder returns.
- Apellis Pharmaceutical Deal: In the transaction between Apellis Pharmaceuticals, Inc. and Biogen, Apellis shareholders are expected to receive $41.00 per share in cash along with two non-transferable rights of $2.00 each, providing additional potential earnings and enhancing investment appeal.
- Olaplex Acquisition Case: In the deal between Olaplex Holdings, Inc. and Henkel US Operations, Olaplex shareholders are expected to receive $2.06 per share in cash, offering direct cash returns to shareholders and boosting market confidence.
- KORE Group Transaction: In the transaction involving KORE Group Holdings, Inc. and Searchlight Capital Partners, KORE shareholders are expected to receive $9.25 per share in cash, providing substantial cash flow to shareholders and further solidifying their market position.
See More
